Better preclinical models improve clinical success. Human primary cell–based drug efficacy and hematotoxicity assays are new approach methodologies (NAMs) that can deliver clinically predictive insights
Understanding how a drug candidate is metabolized, transported, and cleared is an essential part of the drug development process. Discovery Life Sciences’ (Discovery’s) Gentest® ADME
Discovery Life Sciences provides precise and accurate measurement of analytes in biological matrices to support safe, informed research decisions. We offer both qualitative and quantitative
Discovery Life Sciences (Discovery) accelerates the path from biospecimen to breakthrough — delivering high-quality samples, advanced analytics, and integrated laboratory services that move research forward
Discovery Life Sciences (Discovery) accelerates the path from biospecimen to breakthrough — delivering high-quality samples, advanced analytics, and integrated laboratory services that move research forward
Discovery Life Sciences (Discovery) scientists pioneered the development of cryopreserved dissociated cells from both diseased and normal solid tissues, establishing a transformative tool for oncology
Discovery Life Sciences excels in custom panel development and validation, tailored to your specific needs, markers of interest, and intended applications. We deliver flexible solutions,
In the race to develop next-generation ADCs—targetingTROP2, HER2, EGFR, and beyond—the biggest barriersaren’t always biological. Hidden pitfalls like inconsistenttarget expression, unclear mechanisms of action, andoff-tumor
Discovery’s mIF services makes it easy to visualize and analyze complex tissue samples, taking your spatial biology research to the next level. We deliver multidimensional
